Brief: Intercept Announces FDA Advisory Committee Meeting Date On Obeticholic Acid

Intercept Pharmaceuticals

10/03/2023 14:22

March 10 (Reuters) - Intercept Pharmaceuticals Inc  ICPT.O :
    * INTERCEPT ANNOUNCES FDA ADVISORY COMMITTEE MEETING DATE
FOR
OBETICHOLIC ACID AS A TREATMENT FOR PRE-CIRRHOTIC LIVER FIBROSIS
DUE TO NASH
    * INTERCEPT PHARMACEUTICALS INC - PDUFA TARGET ACTION DATE
IS JUNE
22, 2023
    * INTERCEPT PHARMACEUTICALS INC - PDUFA TARGET ACTION DATE
IS JUNE
22, 2023
    * INTERCEPT PHARMACEUTICALS INC - ADVISORY COMMITTEE MEETING
SCHEDULED FOR MAY 19, 2023

Source text for Eikon:  ID:nGNX42vvvc 
Further company coverage:  ICPT.O